Cutera share price today

(CUTR)

Cutera share price is $0.48 & ₹41.53 as on 17 Jan 2025, 10.30 hrs IST

$0.48

▲

0.08

(19.16%)

Market is closed - opens 8 PM, 21 Jan 2025

View live Cutera share price in Dollar and Rupees. Guide to invest in Cutera stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cutera, along with analyst recommendations, forecasts, and comprehensive financials.

Cutera share price movements

Today's Low: $0.40
Today's High: $0.48
$0.48
16.56%
Downside
Day's Volatility :16.56%
Upside
0.0%
52 Weeks Low: $0.28
52 Weeks High: $3.18
$0.48
41.52%
Downside
52 Weeks Volatility :91.17%
Upside
84.91%

Cutera Returns

Period	Cutera, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-31.76%	-8.5%	0.0%
6 Months	-70.74%	-5.2%	0.0%
1 Year	-82.53%	0.5%	0.0%
3 Years	-98.57%	7.2%	-12.6%

Cutera Key Statistics

in dollars & INR

Previous Close	$0.4003
Open	$0.39
Today's High	$0.4898
Today's Low	$0.4005
Market Capitalization	$9.6M
Today's Volume	$537.4K
52 Week High	$3.18
52 Week Low	$0.2807
Revenue TTM	$155.2M
EBITDA	$-124.0M
Earnings Per Share (EPS)	$-7.18
Profit Margin	-92.59%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-4447.26%

How to invest in Cutera from India?

It is very easy for Indian residents to invest directly in Cutera from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cutera stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cutera or CUTR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cutera or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cutera shares which would translate to 1.802 fractional shares of Cutera as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cutera, in just a few clicks!

Returns in Cutera for Indian investors in Rupees

Investment Value

₹1,00,000

Cutera investment value today

Current value as on today

₹21,701

Returns

₹78,299

(-78.3%)

Returns from Cutera Stock

₹82,418 (-82.42%)

Dollar Returns

₹4,118 (+4.12%)

Indian investors sentiment towards Cutera

50%

Period: Oct 21, 2024 to Jan 19, 2025. Change in 30 Days versus previous period

Search volume for Cutera on INDmoney from India has grown in the last 30 days as on Jan 20, 2025. 50% more investors are searching Cutera in the last 30 days versus the previous period.

Global Institutional Holdings in Cutera

PURA VIDA INVESTMENTS, LLC
5.77%
Vanguard Group Inc
4.53%
Millennium Management LLC
3.79%
Hawk Ridge Management LLC
2.20%
Gamco Investors, Inc. Et Al
1.74%
BOOTHBAY FUND MANAGEMENT, LLC
1.62%

Analyst Recommendation on Cutera

Buy

63%Buy

36%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Cutera(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cutera

What analysts predicted

Upside of 316.67%

Target:

$2.00

Current:

$0.48

Insights on Cutera

Price Movement
In the last 7 days, CUTR stock has moved up by 18.8%
Decreasing Revenue
Revenue is down for the last 7 quarters, 67.35M → 32.5M (in $), with an average decrease of 11.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -22.77M → -39.01M (in $), with an average decrease of 33.2% per quarter
CUTR vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 61.9% return, outperforming this stock by 144.6%
CUTR vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 127.1% return, outperforming this stock by 225.7%
Price to Sales
ForCUTR every $1 of sales, investors are willing to pay $0.1, whereas for Boston Scientific Corp., the investors are paying $9.1 for every $1 of sales.

Cutera Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$162.7M	↑ 7.41%
Net Income	$-30.8M	↓ 202.59%
Net Profit Margin	-18.91%	↓ 38.71%

	FY19	Y/Y Change
Revenue	$181.7M	↑ 11.67%
Net Income	$-12.3M	↓ 59.87%
Net Profit Margin	-6.8%	↑ 12.11%

	FY20	Y/Y Change
Revenue	$147.7M	↓ 18.73%
Net Income	$-23.9M	↑ 93.37%
Net Profit Margin	-16.17%	↓ 9.37%

	FY21	Y/Y Change
Revenue	$231.3M	↑ 56.6%
Net Income	$2.1M	↓ 108.64%
Net Profit Margin	0.89%	↑ 17.06%

	FY22	Y/Y Change
Revenue	$252.4M	↑ 9.14%
Net Income	$-82.3M	↓ 4093.21%
Net Profit Margin	-32.62%	↓ 33.51%

	FY23	Y/Y Change
Revenue	$212.4M	↓ 15.86%
Net Income	$-162.8M	↑ 97.76%
Net Profit Margin	-76.67%	↓ 44.05%

	Q2 FY23	Q/Q Change
Revenue	$61.2M	↓ 9.11%
Net Income	$-31.6M	↑ 306.32%
Net Profit Margin	-51.69%	↓ 40.13%

	Q3 FY23	Q/Q Change
Revenue	$46.5M	↓ 24.04%
Net Income	$-44.3M	↑ 39.91%
Net Profit Margin	-95.21%	↓ 43.52%

	Q4 FY23	Q/Q Change
Revenue	$46.5M	↓ 0.05%
Net Income	$-44.3M	↑ 0.0%
Net Profit Margin	-95.26%	↓ 0.05%

	Q1 FY24	Q/Q Change
Revenue	$38.8M	↓ 16.53%
Net Income	$-22.8M	↓ 48.55%
Net Profit Margin	-58.72%	↑ 36.54%

	Q2 FY24	Q/Q Change
Revenue	$34.4M	↓ 11.38%
Net Income	$-24.7M	↑ 8.35%
Net Profit Margin	-71.8%	↓ 13.08%

	Q3 FY24	Q/Q Change
Revenue	$32.5M	↓ 5.46%
Net Income	$-39.0M	↑ 58.09%
Net Profit Margin	-120.06%	↓ 48.26%

	FY18	Y/Y Change
Profit	$80.4M	↓ 6.65%

	FY19	Y/Y Change
Profit	$98.2M	↑ 22.12%

	FY20	Y/Y Change
Profit	$75.8M	↓ 22.81%

	FY21	Y/Y Change
Profit	$133.1M	↑ 75.67%

	FY22	Y/Y Change
Profit	$139.8M	↑ 5.05%

	FY23	Y/Y Change
Profit	$41.5M	↓ 70.33%

	Q2 FY23	Q/Q Change
Profit	$28.1M	↓ 27.6%

	Q3 FY23	Q/Q Change
Profit	$46.5M	↑ 65.75%

	Q4 FY23	Q/Q Change
Profit	$3.4M	↓ 92.6%

	Q1 FY24	Q/Q Change
Profit	$11.0M	↑ 220.49%

	Q2 FY24	Q/Q Change
Profit	$6.3M	↓ 43.18%

	Q3 FY24	Q/Q Change
Profit	$1.8M	↓ 71.07%

	FY18	Y/Y Change
Operating Cash Flow	$307.0K	↓ 97.85%
Investing Cash Flow	$10.8M	↓ 39.11%
Financing Cash Flow	$788.0K	↓ 102.5%

	FY19	Y/Y Change
Operating Cash Flow	$-2.2M	↓ 822.15%
Investing Cash Flow	$1.1M	↓ 90.1%
Financing Cash Flow	$1.4M	↑ 79.44%

	FY20	Y/Y Change
Operating Cash Flow	$-17.0M	↑ 664.82%
Investing Cash Flow	$6.4M	↑ 498.78%
Financing Cash Flow	$31.3M	↑ 2113.44%

	FY21	Y/Y Change
Operating Cash Flow	$1.2M	↓ 107.28%
Investing Cash Flow	$-944.0K	↓ 114.78%
Financing Cash Flow	$117.5M	↑ 275.51%

	FY22	Y/Y Change
Operating Cash Flow	$-67.0M	↓ 5524.7%
Investing Cash Flow	$-194.2M	↑ 20470.13%
Financing Cash Flow	$242.9M	↑ 106.71%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-31.3M	↑ 83.63%
Investing Cash Flow	$45.2M	↑ 79.49%
Financing Cash Flow	$-153.0K	↓ 100.17%

Cutera Technicals Summary

Sell

Neutral

Buy

Cutera is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cutera Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cutera, Inc.	45.74%	-70.74%	-82.53%	-98.57%	-98.41%
Medtronic Plc	8.21%	11.07%	1.86%	-16.59%	-27.26%
Edwards Lifesciences Corp.	-6.72%	-20.7%	-7.16%	-38.06%	-13.85%
Boston Scientific Corp.	9.79%	26.05%	62.43%	129.6%	123.97%
Stryker Corporation	4.62%	11.98%	22.39%	50.55%	76.63%
Abbott Laboratories	-0.73%	9.41%	-0.62%	-9.81%	23.54%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cutera, Inc.	NA	NA	9.05	-5.04	-44.47	-0.26	NA	-12.55
Medtronic Plc	26.94	26.94	1.5	5.45	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.94	26.94	6.41	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	81.54	81.54	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	41.14	41.14	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.49	34.49	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cutera, Inc.	Buy	$9.6M	-98.41%	NA	-92.59%
Medtronic Plc	Buy	$112.9B	-27.26%	26.94	12.06%
Edwards Lifesciences Corp.	Buy	$41.2B	-13.85%	26.94	65.86%
Boston Scientific Corp.	Buy	$145.4B	123.97%	81.54	11.26%
Stryker Corporation	Buy	$146.2B	76.63%	41.14	16.34%
Abbott Laboratories	Buy	$196.8B	23.54%	34.49	13.99%

About Cutera

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Organization	Cutera
Employees	430
CEO	Mr. Taylor C. Harris
Industry	Health Technology

Management People of Cutera

Name	Title
Mr. Taylor C. Harris	President, CEO & Director
Mr. Stuart D. Drummond	Chief Financial Officer
Mr. Jeffrey S. Jones	Chief Operating Officer
Dr. Stephana E. Patton J.D., Ph.D.	Chief Legal Officer
Mr. Charles G. Thier	Chief Information Officer
Greg Barker	Vice President of FP&A and Investor Relations
Mr. Steve Kreider	Senior Vice President of Global Marketing
Mr. Brent Hauser	President of International
Shelby Eckerman	Vice President of Finance

Important FAQs about investing in Cutera from India :

What is Cutera share price today?

Cutera share price today stands at $0.48, Open: $0.39 ; Previous Close: $0.40 ; High: $0.48 ; Low: $0.40 ; 52 Week High: $3.18 ; 52 Week Low: $0.28. The stock opens at $0.39, after a previous close of $0.40. The stock reached a daily high of $0.48 and a low of $0.40, with a 52-week high of $3.18 and a 52-week low of $0.28.

Can Indians buy Cutera shares?

Yes, Indians can invest in the Cutera (CUTR) from India.

With INDmoney, you can buy Cutera at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cutera at zero transaction cost.

How can I buy Cutera shares from India?

It is very easy to buy Cutera from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cutera be purchased?

Yes, you can buy fractional shares of Cutera with INDmoney app.

What are the documents required to start investing in Cutera stocks?

To start investing in Cutera, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.